About this trial

An observational cohort study to evaluate the benefit of functional parameters, radiomics and blood biomarkers to predict the outcome of patients with acute heart failure.

Eligibility criteria

Qualifiers

Clinical diagnosis of acute heart failure, including all stages of cardiogenic shock, de novo heart failure as well as decompensated chronic heart failure.

Hospitalisation due to acute heart failure or new-onset acute heart failure during a hospitalisation de to a different cause. Out-patients with acute heart failure are not included.

Disqualifiers

Age < 18 years

No written informed consent.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
University Medical Center Hamburg-Eppendorf20246, Hamburg Germany

Sponsors and collaborators

Universitätsklinikum Hamburg-Eppendorf

Lead sponsor